The recent activity involving Nickolas Stavropoulos, a director at Ameresco, Inc., provides specific data points regarding internal confidence within the organization. On May 15, 2026, Mr. Stavropoulos sold shares of the company’s Class A Common Stock, totaling $46,070. This disposition involved selling 1,355 shares at a price of $34.0 per share.
These sales were structured under a Rule 10b5-1 trading plan that Mr. Stavropoulos had initially adopted on September 8, 2025. It is noteworthy that the sale price of $34.0 represents a premium when compared to the stock's current market price of $28.93. Despite some recent fluctuations in the stock's value, shares have reportedly delivered a strong return of 97% over the last year.
In conjunction with the sales, Mr. Stavropoulos also acquired additional equity through the exercise of existing stock options. Specifically, he purchased 1,355 shares of Class A Common Stock by exercising options at $16.33 per share, resulting in a total transaction value of $22,127.
Following these combined transactions, Mr. Stavropoulos' direct holdings include 14,111 shares of Ameresco Class A Common Stock. Furthermore, his derivative positions maintain an exposure to the company through stock options that grant the right to purchase 6,000 additional shares of Class A Common Stock. These specific options have an expiration date set for April 23, 2029. The vesting schedule associated with these options began on April 24, 2020, initially requiring a 20% vestment, with the remaining balance to be released in four equal annual installments.
Beyond the director's personal trading activity, Ameresco has been executing significant corporate growth strategies. The company recently finalized a joint venture agreement with HA Sustainable Infrastructure Capital Inc., leading to the creation of Neogenyx Fuels. Under this structure, Ameresco maintains a 70% ownership stake in the new entity.
This joint venture is valued at approximately $1.8 billion and is specifically designed to bolster Ameresco's existing biofuels platform. HA Sustainable Infrastructure Capital committed $400 million toward supporting Neogenyx Fuels' growth, while Ameresco received $100 million upon the closing of the transaction.
The expansion efforts are already underway, as Neogenyx Fuels has commenced construction on a renewable natural gas facility located in Nebraska. This facility is designed to convert manure into renewable natural gas for various energy applications.
Sector analysts and financial institutions have also provided updated assessments of Ameresco's valuation and prospects. According to InvestingPro analysis, the company appears undervalued at its current market levels. For investors seeking a deeper understanding of the firm’s financial health and potential growth trajectories, comprehensive Pro Research Reports are available, covering AMRC and over 1,400 other US equities.
In related developments highlighting operational strength, Anaergia Inc. secured a contract valued at C$58 million. This contract involves deploying anaerobic digestion technology at a Neogenyx Fuels agricultural facility situated in the United States, reinforcing the expansion of renewable fuel infrastructure.
Financial analysts have adjusted their price targets for Ameresco based on these developments. Cantor Fitzgerald raised its price target for Ameresco to $45, specifically citing the formation of the Neogenyx joint venture as a key contributing factor. Concurrently, Jefferies adjusted its price target down to $35 after conducting a valuation review. This revision occurred despite Ameresco reporting first-quarter revenue of $401 million, which exceeded consensus estimates by 9%.
Risks
- The price target adjustment made by Jefferies to $35 following a valuation review suggests potential downward pressure on the stock, despite strong quarterly revenue reports.
- While the Neogenyx joint venture is valued at $1.8 billion, its successful execution and ability to meet growth expectations remain an inherent uncertainty for the biofuels sector.
- The market's reaction to director-level trading activity, such as Mr. Stavropoulos’ sales of shares under a 10b5-1 plan, can introduce variable sentiment regarding internal confidence.
More from Insider Trading
Risks
- The price target adjustment made by Jefferies to $35 following a valuation review suggests potential downward pressure on the stock, despite strong quarterly revenue reports.
- While the Neogenyx joint venture is valued at $1.8 billion, its successful execution and ability to meet growth expectations remain an inherent uncertainty for the biofuels sector.
- The market's reaction to director-level trading activity, such as Mr. Stavropoulos’ sales of shares under a 10b5-1 plan, can introduce variable sentiment regarding internal confidence.